DD239206A5 - Verfahren zur stabilisierung von bacampicillinhydrochlorid - Google Patents
Verfahren zur stabilisierung von bacampicillinhydrochlorid Download PDFInfo
- Publication number
- DD239206A5 DD239206A5 DD85282660A DD28266085A DD239206A5 DD 239206 A5 DD239206 A5 DD 239206A5 DD 85282660 A DD85282660 A DD 85282660A DD 28266085 A DD28266085 A DD 28266085A DD 239206 A5 DD239206 A5 DD 239206A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- bacampicillin hydrochloride
- bacampicillin
- carboxylic acids
- hydrochloride
- weight
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/04—Preparation
- C07D499/14—Preparation of salts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8405611A SE8405611D0 (sv) | 1984-11-09 | 1984-11-09 | Process for stabilization of bacampicillin hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
DD239206A5 true DD239206A5 (de) | 1986-09-17 |
Family
ID=20357678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD85282660A DD239206A5 (de) | 1984-11-09 | 1985-11-08 | Verfahren zur stabilisierung von bacampicillinhydrochlorid |
Country Status (23)
Country | Link |
---|---|
US (1) | US4626532A (xx) |
EP (1) | EP0187626A1 (xx) |
JP (1) | JPS61115031A (xx) |
KR (1) | KR860004065A (xx) |
CN (1) | CN85108260A (xx) |
AU (1) | AU581694B2 (xx) |
CS (1) | CS251799B2 (xx) |
DD (1) | DD239206A5 (xx) |
DK (1) | DK509085A (xx) |
EG (1) | EG17292A (xx) |
ES (1) | ES8704176A1 (xx) |
FI (1) | FI854340A (xx) |
GB (1) | GB2167067B (xx) |
GR (1) | GR852706B (xx) |
HU (1) | HUT40135A (xx) |
IL (1) | IL76727A (xx) |
NZ (1) | NZ214096A (xx) |
PH (1) | PH21760A (xx) |
PL (1) | PL256116A1 (xx) |
PT (1) | PT81455B (xx) |
SE (1) | SE8405611D0 (xx) |
YU (1) | YU167085A (xx) |
ZA (1) | ZA858043B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1101497T3 (da) * | 1998-08-04 | 2008-03-31 | Schering Plough Animal Health | Stabiliserende olieagtige præparationer af tobicillin (beta-lactam antibiotikum) |
US20030180249A1 (en) * | 2002-03-18 | 2003-09-25 | Khanna Satish Chandra | Dosage forms for hygroscopic active ingredients |
US8986781B2 (en) * | 2005-10-27 | 2015-03-24 | Corning Incorporated | Immobilized multi-layer artificial membrane for permeability measurements (PAMPA) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1293590A (en) * | 1969-11-11 | 1972-10-18 | Leo Pharm Prod Ltd | New penicillanic acid derivatives |
US3873521A (en) * | 1970-09-17 | 1975-03-25 | Astra Laekemedel Ab | Esters of {60 -amino penicillins |
JPS56140915A (en) * | 1980-04-07 | 1981-11-04 | Yamanouchi Pharmaceut Co Ltd | Pharmaceutical preparation for solid drug |
US4321253A (en) * | 1980-08-22 | 1982-03-23 | Beatty Morgan L | Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration |
IE51846B1 (en) * | 1980-11-17 | 1987-04-15 | Leo Pharm Prod Ltd | Pharmaceutical preparation for veterinary use and an appliance containing it |
SE8103843L (sv) * | 1981-06-18 | 1982-12-19 | Astra Laekemedel Ab | Farmaceutisk mixtur |
SE8203953D0 (sv) * | 1982-06-24 | 1982-06-24 | Astra Laekemedel Ab | Pharmaceutical mixture |
-
1984
- 1984-11-09 SE SE8405611A patent/SE8405611D0/xx unknown
-
1985
- 1985-10-16 IL IL76727A patent/IL76727A/xx unknown
- 1985-10-18 ZA ZA858043A patent/ZA858043B/xx unknown
- 1985-10-21 YU YU01670/85A patent/YU167085A/xx unknown
- 1985-10-29 US US06/792,507 patent/US4626532A/en not_active Expired - Fee Related
- 1985-10-31 EP EP85850351A patent/EP0187626A1/en not_active Withdrawn
- 1985-11-05 FI FI854340A patent/FI854340A/fi not_active Application Discontinuation
- 1985-11-05 DK DK509085A patent/DK509085A/da not_active Application Discontinuation
- 1985-11-06 HU HU854267A patent/HUT40135A/hu unknown
- 1985-11-06 PL PL25611685A patent/PL256116A1/xx unknown
- 1985-11-06 AU AU49382/85A patent/AU581694B2/en not_active Ceased
- 1985-11-06 NZ NZ214096A patent/NZ214096A/xx unknown
- 1985-11-07 EG EG715/85A patent/EG17292A/xx active
- 1985-11-07 CS CS858022A patent/CS251799B2/cs unknown
- 1985-11-08 DD DD85282660A patent/DD239206A5/de unknown
- 1985-11-08 ES ES548698A patent/ES8704176A1/es not_active Expired
- 1985-11-08 PT PT81455A patent/PT81455B/pt unknown
- 1985-11-08 GB GB08527612A patent/GB2167067B/en not_active Expired
- 1985-11-08 KR KR1019850008331A patent/KR860004065A/ko not_active Application Discontinuation
- 1985-11-08 GR GR852706A patent/GR852706B/el unknown
- 1985-11-08 JP JP60249149A patent/JPS61115031A/ja active Pending
- 1985-11-08 PH PH33042A patent/PH21760A/en unknown
- 1985-11-09 CN CN198585108260A patent/CN85108260A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
PT81455B (en) | 1987-09-17 |
YU167085A (en) | 1988-12-31 |
SE8405611D0 (sv) | 1984-11-09 |
EG17292A (en) | 1990-08-30 |
GB2167067B (en) | 1988-06-22 |
US4626532A (en) | 1986-12-02 |
ES548698A0 (es) | 1987-03-16 |
PH21760A (en) | 1988-02-18 |
GR852706B (xx) | 1986-03-10 |
ZA858043B (en) | 1987-04-29 |
EP0187626A1 (en) | 1986-07-16 |
NZ214096A (en) | 1988-09-29 |
FI854340A0 (fi) | 1985-11-05 |
JPS61115031A (ja) | 1986-06-02 |
PL256116A1 (en) | 1988-05-12 |
PT81455A (en) | 1985-12-01 |
CN85108260A (zh) | 1986-04-10 |
ES8704176A1 (es) | 1987-03-16 |
IL76727A (en) | 1989-09-10 |
DK509085D0 (da) | 1985-11-05 |
GB8527612D0 (en) | 1985-12-11 |
FI854340A (fi) | 1986-05-10 |
AU581694B2 (en) | 1989-03-02 |
DK509085A (da) | 1986-05-10 |
GB2167067A (en) | 1986-05-21 |
CS251799B2 (en) | 1987-08-13 |
AU4938285A (en) | 1986-05-15 |
KR860004065A (ko) | 1986-06-16 |
IL76727A0 (en) | 1986-02-28 |
HUT40135A (en) | 1986-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69936352T3 (de) | Stabilisierung von rapamycinen oder rapamycinderivaten | |
DE2332878C2 (de) | Salze von Cephalosporinen mit Arginin und Lysin, ihre Herstellung und injizierbare pharmazeutische Zubereitungen | |
DE2415980C2 (xx) | ||
DE3051205C2 (de) | Pharmazeutische Zubereitung mit antihypartensiver Wirkung, enthaltend eine Chinolonverbindung | |
CH641358A5 (de) | Pharmazeutisches praeparat, enthaltend ein herzglykosid in kombination mit einem polymeren und verfahren zur herstellung desselben. | |
DE2527914A1 (de) | Vincaminverbindungen, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische mittel | |
DE2323187C2 (de) | Verfahren zur Herstellung einer stabilisierten, pulverförmigen Secretinzubereitung | |
DE2506622C2 (de) | Antibiotisch wirksames Arzneimittel | |
AT400519B (de) | Pharmazeutische zubereitungen mit einem gehalt an ace-inhibitor und dessen stabilisierung | |
CH642261A5 (de) | Arzneipraeparat auf der basis eines salzes der acetylsalicylsaeure und einer basischen aminosaeure und verfahren zu seiner herstellung. | |
DE3212882C2 (xx) | ||
DE1811518B2 (de) | Daunorubicinderivale, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
DD239206A5 (de) | Verfahren zur stabilisierung von bacampicillinhydrochlorid | |
EP0164588A2 (de) | Dihydropyridinpräparate und Verfahren zu ihrer Herstellung | |
DD229410A5 (de) | Verfahren zur herstellung von kristallinem cephalexinhydrochloridmonohydrat | |
DE69824971T2 (de) | Stabilisierte Zusammensetzung aus Tetrahydropyrrolo [1,2-a] Pyrazin-4-Spiro-3'-Pyrrolidin | |
DE3789264T2 (de) | Beta-lactam-antibiotika. | |
DE2632118C3 (de) | Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel | |
EP0116358B1 (de) | Komplexe von Prostaglandinen | |
DE2748291C3 (de) | Substituierte 13-Benzodioxan-4one und Verfahren zu ihrer Herstellung sowie Verwendung dieser Verbindungen bei der Bekämpfung von Entzündungen | |
DE69115102T2 (de) | Stabilisator für eine 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide enthaltende Zusammensetzung und Stabilisierungsverfahren. | |
DE3786187T2 (de) | Chemische Verbindung. | |
DE1695298C3 (de) | S-Acetamido-e-methyl-e-n-propyl-striazolo eckige Klammer auf 4,3-a eckige Klammer zu pyrazin und Verfahren zu seiner Herstellung und Arzneimittel | |
DE2711149C3 (de) | N-Substituierte[4-Chlor-6-(23-xylidino)-2· pyrimidinyl- thio] essigsäureamide sowie Verfahren zu deren Herstellung | |
DE1620177C3 (de) | N-(2-Hydroxyäthyl)-piperazinocarboxymethyl-tetracyclin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |